{"nct_id":"NCT04484623","title":"Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2020-10-01","start_date_type":"ACTUAL","primary_completion_date":"2024-01-29","primary_completion_date_type":"ACTUAL","completion_date":"2029-10-25","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}